Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS)

This is a protocol protocol: An action plan that describes what will be done in a clinical trial and how it will be carried out. This plan is reviewed and approved by a committee at each place doing the clinical trial. This committee is known as the Institutional Review Board. for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of both supportive and disease-modifying drug treatments for anaemia in people with MDS, comparing them to each other, or the standard of care with or without placebo placebo: A placebo is an inactive pill, liquid, or powder that has no treatment value. .